Oncology

Latest News

NSCLC | Image: Lung Cancer Foundation of America
Zongertinib Shows Durable Responses With No Interstitial Lung Disease in HER2-Mutated Advanced NSCLC

April 28th 2025

Results could give patients with HER2-mutated non–small cell lung cancer (NSCLC) an oral therapy option.

Considering the life-threatening risk of TLS, the researchers underscored the importance of identifying patients at particular risk of the complication. | Image credit: mi_viri - stock.adobe.com
Optimized Strategies Needed for TLS Prevention, Intervention in SCLC

April 23rd 2025

Diabetes monitoring | Image credit: abidika - stock.adobe.com
New-Onset Type 2 Diabetes Linked to Higher Cancer Risk

April 23rd 2025

Vitamin D | Image credit: Galina Zhigalova - stock.adobe.com
Vitamin D’s Potential Role in Colorectal Cancer Prevention, Immune Health

April 23rd 2025

The study highlighted symptom patterns in the short-term preceding ED visits and unplanned hospitalizations using a previously validated natural language processing a pipeline. | Image credit: Tyler Olson - stock.adobe.com
Symptom Documentation Differences in Acute Cancer Care Suggest Sociodemographic Disparities

April 22nd 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

The Importance of Including Primary Care Physicians in a Patient's Cancer Journey
June 1st 2019

The Importance of Including Primary Care Physicians in a Patient's Cancer Journey

Samantha DiGrande
“How do you currently collaborate with your primary care colleagues in caring for patients with cancer?” This was how Larissa Nekhlyudov, MD, MPH, opened a session titled “Bringing the Primary Care Physician Back Into Cancer Care,” during the American Society of Clinical Oncology’s Annual Meeting, held in Chicago, Illinois from May 31-June 4, 2019.
Unlocking the Promise of Vaccines for Cancer Treatment
May 31st 2019

Unlocking the Promise of Vaccines for Cancer Treatment

Jaime Rosenberg
This is part 3 of a 3-part vaccine series covering the potential of vaccines for infectious diseases, the impact of the antivaccination movement, and the promise of vaccines for cancer treatment. Read part 1 and part 2.
KOL Corner: Amy Ellis Discusses Practice Transformation With Jess Quiring of New Mexico Cancer Center
May 30th 2019

KOL Corner: Amy Ellis Discusses Practice Transformation With Jess Quiring of New Mexico Cancer Center

In the first of a series of interviews with key opinion leaders (KOLs), Amy Ellis, director of quality and value-based care at Northwest Medical Specialties, discusses practice transformation with Jess Quiring, a patient navigator at New Mexico Cancer Center.
Pediatric Patients Wait an Average of 6.5 Years Longer Than Adults to Access New Oncology Drugs
May 29th 2019

Pediatric Patients Wait an Average of 6.5 Years Longer Than Adults to Access New Oncology Drugs

Jaime Rosenberg
The median lag time from first-in-human to first-in-child trials of oncology drugs that were ultimately approved by FDA is 6.5 years.
David Ortiz Discusses Making Adjustments, Reacting to Performance Period Reports in OCM
May 28th 2019

David Ortiz Discusses Making Adjustments, Reacting to Performance Period Reports in OCM

The long time between when a performance period ends and when the report comes out in the Oncology Care Model (OCM) can make it difficult to measure the impact specific changes are making, said David Ortiz, OCM program director at Montefiore Einstein Center for Cancer Care.
Immunotherapy and the OCM: Costs and Utilization
May 21st 2019

Immunotherapy and the OCM: Costs and Utilization

Oncology Care Model: Stakeholder Support
May 21st 2019

Oncology Care Model: Stakeholder Support

Improving Upon the Oncology Care Model Framework
May 21st 2019

Improving Upon the Oncology Care Model Framework

Oncology Care Model: Measuring Value
May 21st 2019

Oncology Care Model: Measuring Value

Evolving Versions of the Oncology Care Model
May 21st 2019

Evolving Versions of the Oncology Care Model

Novel Therapies & The OCM: Treatment Decisions
May 21st 2019

Novel Therapies & The OCM: Treatment Decisions

Oncology Care Model: Counseling Patients
May 21st 2019

Oncology Care Model: Counseling Patients

Opportunities of the Oncology Care Model
May 21st 2019

Opportunities of the Oncology Care Model

Oncology Care Model: Measuring Performance
May 21st 2019

Oncology Care Model: Measuring Performance

Practice Pathways Under the Oncology Care Model
May 21st 2019

Practice Pathways Under the Oncology Care Model

Oncology Care Model: Multidisciplinary Care
May 21st 2019

Oncology Care Model: Multidisciplinary Care

Oncology Care Model: 2-Sided Financial Risk
May 21st 2019

Oncology Care Model: 2-Sided Financial Risk

A Current Look at the Oncology Care Model
May 21st 2019

A Current Look at the Oncology Care Model

Barry Russo: Alliances Between Practices Are Invaluable to the Future of Cancer Care
May 19th 2019

Barry Russo: Alliances Between Practices Are Invaluable to the Future of Cancer Care

Alliances are going to help community oncology participate in things that, as individual practices, they don‘t have the opportunity to do, said Barry Russo, chief executive officer of The Center for Cancer and Blood Disorders.
Feyi Olopade Ayodele on the Importance of Early Cancer Detection in a Value-Based Care System
May 17th 2019

Feyi Olopade Ayodele on the Importance of Early Cancer Detection in a Value-Based Care System

With CancerIQ, we’re really going to be helping push population health into the oncology arena where we can hopefully predict and preempt this very costly and devastating disease well in advance, says Feyi Olopade Ayodele, MBA, chief executive officer at CancerIQ.
David Ortiz Highlights Changes in Care as a Result of OCM
May 16th 2019

David Ortiz Highlights Changes in Care as a Result of OCM

The Oncology Care Model (OCM) has set off a ripple of change in cancer care that extends beyond the patients who are in the model, said David Ortiz, OCM program director at Montefiore Einstein Center for Cancer Care.
Physicians More Likely to Order Cancer Screening in the Morning
May 14th 2019

Physicians More Likely to Order Cancer Screening in the Morning

Jaime Rosenberg
Patients with primary care appointments in the morning were more likely to have orders for and receive recommended breast and colorectal cancer screenings.
Connecting Cancer Practices to Share Data, Deliver Better Care, Identify Best Practices
May 14th 2019

Connecting Cancer Practices to Share Data, Deliver Better Care, Identify Best Practices

Outcomes for patients with cancer are continuously improving, but the increasingly complex healthcare system, new payment and delivery models that place more risk on practices, and rising costs of therapies has made it difficult for independent oncology practices to thrive and survive. However, independent practices present an important part of cancer care, delivering care to patients who are not near large hospital-based systems at lower costs.
Beth Wittmer Details the Components of a Care Management Team
May 14th 2019

Beth Wittmer Details the Components of a Care Management Team

Pharmacists, social support services, an information technology team, and financial counselors all come together to encompass the care for the patient, says Beth Wittmer, RN, OCN, manager of care management at Florida Cancer Specialists and Research Institute.
Dr Ray Page Details Using Triage Pathways and Scaling Them Across Multiple Practices
May 10th 2019

Dr Ray Page Details Using Triage Pathways and Scaling Them Across Multiple Practices

Triage pathways can transform practices and save practices and CMS money by keeping people out of the emergency department and hospital, said Ray Page, DO, PhD, president and director of research at The Center for Cancer and Blood Disorders.
Dr Michael Kolodziej Weighs the Pros and Cons of Government Influence on Payment Reform
May 6th 2019

Dr Michael Kolodziej Weighs the Pros and Cons of Government Influence on Payment Reform

Some of the health policies coming out of Washington, DC, are clever, but there might be too much coming out for practices to keep up with, said Michael Kolodziej, MD, vice president and chief innovation officer at ADVI Health, Inc.
Site Logo
May 6th 2019

Beyond Satisfaction Scores: Exploring Emotionally Adverse Patient Experiences

Laura M. Holdsworth, PhD Dani L. Zionts, MScPH Karen Marie De Sola-Smith, PhD Melissa Valentine, PhD Marcy D. Winget, PhD Steven M. Asch, MD
This study explores the causes of emotionally adverse patient experiences in cancer care and presents a taxonomy for analyzing free-text patient data.
Treatment Could Prevent Patients With Cancer From Experiencing Jawbone Damage After Oral Surgery
May 4th 2019

Treatment Could Prevent Patients With Cancer From Experiencing Jawbone Damage After Oral Surgery

Laura Joszt, MA
Patients with cancer who receive high doses of bisphosphonates, used to treat bone cancer, can experience jaw damage. New preclinical research published in Bone Science Direct could prevent these patients from experiencing this loss of jawbone tissue after routine oral surgery.
Feyi Olopade Ayodele Highlights Positive Outcomes of Genetic Screening for Cancer
May 4th 2019

Feyi Olopade Ayodele Highlights Positive Outcomes of Genetic Screening for Cancer

Patients who adhere to a CancerIQ cancer prevention plan, or cancer survivorship plan, are more likely to catch a cancer before it grows beyond 1 centimeter, says Feyi Olopade Ayodele, MBA, chief executive officer at CancerIQ.
Barry Russo Explains How Artificial Intelligence Programs Can Simplify Cancer Care
May 3rd 2019

Barry Russo Explains How Artificial Intelligence Programs Can Simplify Cancer Care

An artificial intelligence system can digest what would take a person 29 hours to read in about 30 seconds, so everything is right in front of providers at the point of care, says Barry Russo, chief executive officer of The Center for Cancer and Blood Disorders.
<1
...
242526272829303132
...
184>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo